Myoclonus‐Dystonia Presentation of ATM Gene Mutation in a Canadian Mennonite

肌张力障碍 肌阵挛 介绍(产科) 突变 遗传学 神经科学 心理学 基因 医学 生物 放射科
作者
Jacky Ganguly,Mellany Tuesta Bernaola,Sharan Goobie,Asuri N. Prasad,Mandar Jog
出处
期刊:Movement Disorders Clinical Practice [Wiley]
卷期号:9 (2): 264-267 被引量:5
标识
DOI:10.1002/mdc3.13369
摘要

A 14-year-old female of Canadian Old Colony Mennonite ancestry, product of non-consanguineous union, with normal perinatal history and mild motor developmental delay, presented with gradual onset and progressive involuntary neck jerks and jerky tremulous movements in hands (especially during writing) over a period of 12 months. She had history of occasional gait imbalance in her early childhood, which was non-progressive. There was no history of coordination difficulty or tendency to fall. There was no relevant family history. However, one of her maternal aunts suffered from leukemia (Fig. 1). On examination, there were no telangiectasias. Dystonic neck movements with predominant retrocollis, associated with mild left torticollis and right laterocollis were observed. Myoclonic movements were noted in the hands, on outstretched posture and during writing, which were not stimulus sensitive. Extraocular movements, speech, and cognition were normal. Tone, power, and reflexes were normal in all four limbs. No pyramidal, parkinsonian, or cerebellar signs were noted. Scale for the assessment and rating of ataxia (SARA) score was 0/40. Gait was normal including tandem gait (Video 1). Magnetic resonance imaging (MRI) brain was normal. With a provisional diagnosis of myoclonus-dystonia syndrome (DYT-SGCE), a DYT11 genetics for epsilon-sarcoglycan gene was done and was reported normal. Whole exome sequencing revealed pathogenic compound heterozygous mutations in the ATM gene-missense c.6200C > A (p.Ala2067Asp) in one allele and nonsense c.5932G > T (p.Glu1978Ter) in the other. IgG (7.8 g/L, ref: 6.5-16 g/L), IgA (0.7 g/L, ref: 0.4–3.5 g/L) and IgM (1.3 g/L, ref: 0.5-3 g/L) levels were normal, but serum α-fetoprotein (AFP) was elevated - 90.7 μg/L (ref. <5 μg/L). After 3 months of initial trial with levodopa and carbidopa (100/25) 1 tablet three times a day, her violent retrocolic jerks reduced in severity. Botulinum toxin injections were planned for the residual cervical dystonia. Levetiracetam (up to 1 gram twice daily) was unhelpful for her myoclonus and clonazepam (0.5 mg twice daily) was prescribed. Some improvement in her myoclonic jerks noted on follow-up in 3 months and combined therapy with levodopa-carbidopa and clonazepam has been continued. Ataxia-telangiectasia (A-T) is a childhood-onset, autosomal recessive progressive cerebellar ataxia syndrome because of mutations in the ATM gene. ATM protein kinase regulates multiple signaling cascades responsible for activating cellular checkpoints and repairing DNA strand breaks. ATM also plays a major role in mitochondrial DNA repair and reactive oxygen species (ROS) metabolism. Cerebellar Purkinje cells are rich in mitochondria and are sensitive to oxidative stress induced DNA damage. Null ATM alleles truncate or severely destabilize the ATM protein, leading to lack of functional ATM. The dysfunctional ATM protein in addition induces expression of hypoxia inducible factor (HIF-1) and subsequently vascular endothelial growth factor (VEGF), leading to the development of telangiectasia.1 Tumor suppressor TP53, acts downstream of ATM, also gets impaired and subsequently causes upregulation of AFP gene, leading to increased serum level of AFP.1 On the other hand, myoclonus-dystonia syndrome is classically caused by the mutation in epsilon-sarcoglycan gene (DYT-SGCE). Dysfunction in the neural network comprising mainly the cerebellum along with the thalamus, globus pallidus internus and brainstem, is likely responsible for pathogenesis of M-D.2 Myoclonus-dystonia (M-D) phenotype has also been reported because of mutations in adenylyl cyclase type 5 (ADCY5) (axial hypotonia and nocturnal dyskinesia), potassium channel tetramerization domain containing 17 (KCTD17) (predominant cranio-cervical and speech involvement), calcium voltage-gated channel subunit alpha1 b (CACNA1B) (cardiac arrhythmia and painful cramps), reelin (RELN) (psychiatric features and enhanced startle), protein kinase c gamma (PRKCG) (cerebellar ataxia), G protein subunit alpha L (GNAL) (cervical and laryngeal dystonia), anoctamin 3 (ANO3) (cervical and laryngeal dystonia, and upper limb tremor), tubulin beta 2B class IIb (TUBB2B) (cognitive impairment, and epilepsy), alpha tocopherol transfer protein (TTPA) (ataxia and sensory loss), NK2 homeobox 1 (NKX2-1) (chorea, lung and thyroid dysfunction), tyrosine hydroxylase (TH) (levodopa responsive dystonia) and GTP cyclohydrolase 1 (GCH1) (levodopa responsive dystonia) genes.3 Although dystonic-myoclonic axial jerks4 and myoclonus with appendicular ataxia5 have been reported in variant A-T [(Table 1), M-D phenotype being the only presenting feature without any appendicular or truncal ataxia and other cerebellar signs is rare.6-9 Saunders-Pullman et al10 reported a c.6200 C > A (p.A2067D) mutation in the ATM gene presenting as cervical/brachial onset dystonia with cranial involvement mimicking DYT6 (THAP1) and myoclonus-dystonia presentation mimicking DYT 11 (SGCE) in Canadian Mennonites, without ocular telangiectasia, lack of prominent ataxia and without significant cerebellar atrophy on MRI. Recently Cherian et al11 have reported another case of similar presentation of variant A-T along with slow or hypometric saccades, because of homozygous missense mutation (c. 9156G > C; p. Trp3052Cys) in the ATM gene. Whether the same cerebello-thalamo-cortical circuitry is involved in M-D presentation of variant A-T cases, is unknown. Homozygous c.9022C > T (p.R3008C) or compound heterozygous IVS21 + 1 G > A; IVS55 + 5delG, IVS28-1G > C; IVS34 + 32insAlu, IVS19 + 2 T > G; c.8147 T > C(p.V2716A), c.3383A > G(p.Q1128R); c.8122 G > A(p.D2708N); c.513C > T(p.Y171Y), DupEx64 + 65; c.6108 T > G(p.Y2036X), The c.6200C > A missense mutation in the ATM gene results in a p.Ala2067Asp substitution, leading to protein instability and kinase deficiency. Higher residual level of the ATM protein in this case is likely responsible for less ataxia. Similarly, residual ATM protein can suppress HIF-1 and VEGF expression, resulting in absence of telangiectasia.1 Apart from early onset dystonia, Mennonites carrying this specific mutation (A-TWinnipeg) are found to have high propensity to developing lymphoblastoid malignancies and life-threatening adverse reaction to radiotherapy and chemotherapy.12 In the case series published by Nakamura et al,12 two patients with compound heterozygous mutation also had c.5932G > T (p.Glu1978Ter) mutation apart from the c.6200 C > A (p.Ala2067Asp) mutation, similar to our patient. c.5932G > T mutation in the ATM gene have also been reported in Polish and Russian population.13, 14 Clinicians need to be made aware of variant A-T phenotypes where ataxia can be minimal and other classic findings of A-T like telangiectasia, endocrinopathy, and cerebellar atrophy may be absent. ATM gene mutations can present with phenotypes similar to DYT6, DYT11, progressive myoclonus ataxia (PMA), benign hereditary chorea, juvenile Parkinson's disease, and distal spinal muscular atrophy (SMA). However, because of the risks associated with radiation exposure and higher rates of malignancy in these patients, early diagnosis is of utmost importance. Serum AFP can be a potential cost-effective screening tool and should be considered in patients presenting with early onset dystonia or myoclonus-dystonia, even in the absence of prominent ataxia or telangiectasia. Ataxia telangiectasia remains an important diagnostic consideration not only in patients with early onset cervical/brachial onset dystonia, but also in those with a myoclonus-dystonia phenotype, especially in Mennonite population. (1) Research project: A. Conception, B. Organization, C. Execution; (2) Manuscript Preparation: A. Writing of the First Draft, B. Review and Critique. J.G.: 1B, 1C, 2A M.T.B.: 1B, 1C S.G.: 1B, 2B A.P.: 1A, 1B, 2B M.J.: 1A, 2B The authors confirm that the approval of an institutional review board/patient consent was not required for this work. We also confirm that the patient has given written informed consent for the publication of her video. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. No specific funding was received for this work. The authors declare that there are no conflicts of interest relevant to this work. M.J. receives speaker's fees and research funding from Allergan, AbbVie, Merz Pharmaceuticals, Boston Scientific, Valeo Pharma, Sunovion, and Paladin Labs. M.J. also receives grants from Parkinson society Canada, Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC), Mathematics of Information Technology and Complex Systems (MITACS), Research Council of Norway, Parkinson Society of Southwestern Ontario, Dystonia Medical Research Foundation and Academic Medical Organization of Southwestern Ontario. J.G. receives fellowship funding from the Academic Medical Organization of Southwestern Ontario (AMOSO). M.T.B. receives fellowship funding from the Parkinson Society of Southwestern Ontario (PSSO). A.P. and S.G. do not declare any conflict of interest.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
张大旺完成签到,获得积分10
刚刚
rose发布了新的文献求助10
刚刚
1秒前
yuan完成签到,获得积分10
1秒前
mickiller完成签到,获得积分10
1秒前
清辉影的应助被漫漫采纳,获得10
2秒前
3秒前
杏仁和巧克力完成签到 ,获得积分10
4秒前
liquss完成签到,获得积分10
4秒前
真实的灵安完成签到,获得积分10
4秒前
4秒前
Pululuu完成签到,获得积分10
4秒前
4秒前
5秒前
靓丽的善斓完成签到,获得积分10
5秒前
学术垃圾完成签到,获得积分10
5秒前
5秒前
rose发布了新的文献求助10
6秒前
墩子完成签到,获得积分10
7秒前
NexusExplorer的应助被文艺宛筠采纳,获得10
7秒前
安前进完成签到 ,获得积分10
8秒前
迷人的含灵完成签到,获得积分20
8秒前
吱吱完成签到,获得积分10
8秒前
banana的应助被HHH采纳,获得10
9秒前
墩子发布了新的文献求助10
10秒前
Lny的应助被是希希啊a采纳,获得10
10秒前
10秒前
喜悦忆安完成签到,获得积分10
10秒前
何时春风压西风完成签到,获得积分10
12秒前
12秒前
13秒前
13秒前
15秒前
FG完成签到 ,获得积分10
16秒前
文艺宛筠完成签到,获得积分20
17秒前
17秒前
科研通AI6.4的应助被Liu采纳,获得10
18秒前
安前进关注了科研通微信公众号
18秒前
wulin314完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621